MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517079479 A) filed by Janssen Pharmaceutica Nv, Beerse, Belgium, on Aug. 21, for 'methods for preparing crystalline peptide inhibitors of interleukin-23 receptor.'
Inventor(s) include Breslin, David, T.; Broeckx, Geraldine; Canto, Clara, Anduix; De Dobbelaere, Christopher, Paul; Deniau, Gildas; Di Pretoro, Giustino; Fernandes, Philippe; Kolakovic, Ruzica; Mertens, Nathalie; Patel, Sejal; Pedersen, Betty, Lomstein; Rajan, Gopal; Sun, Dajun; De Fre, Brecht; and Hoeben, Dirk Marie, A.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to methods for preparing crystalline forms of a monocyclic peptide compound, or salts or solvates thereof, which is a peptide inhibitor of the interleukin-23 receptor (IL-23R). The crystalline forms are useful in pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation diseases and related disorders."
The patent application was internationally filed on Jan. 31, 2024, under International application No.PCT/US2024/013815.
Disclaimer: Curated by HT Syndication.
